West Pharmaceutical Data Breach: Cyberattackers Encrypt Systems and Steal Sensitive Information

West Pharmaceutical Services recently revealed that it fell victim to a cyberattack, leading to data theft and system encryption.

The breach was first detected on May 4th, prompting the company to take immediate action. An investigation uncovered that the attacker had accessed and extracted data from the network.

In a filing with the U.S. Securities and Exchange Commission (SEC), West Pharmaceutical Services stated, “On May 7, 2026, [we] determined that a significant cybersecurity breach occurred, resulting in unauthorized data exfiltration and system encryption.”

Upon identifying the intrusion, the company activated its incident response protocols, including shutting down systems globally, notifying law enforcement, and enlisting external cyber-forensic experts.

An ongoing investigation aims to determine the full extent of the breach and the specific data compromised.

West Pharmaceutical Services, a leading American pharmaceutical manufacturing firm, has annual revenues exceeding $3 billion and a global workforce of over 10,800 employees. Specializing in injectable drug packaging and delivery systems, the company plays a crucial role in the healthcare industry.

The cyberattack disrupted the company’s operations worldwide, prompting the temporary shutdown of manufacturing facilities.

While core systems supporting shipping and production have been restored, full system recovery remains incomplete, with no timeline provided for completion.

Despite the incident, the company has not disclosed any financial impact at this time.

West Pharmaceutical Services has implemented measures to prevent the unauthorized dissemination of stolen data, although specific details have not been disclosed.

External cybersecurity experts, including Palo Alto Networks’ Unit 42, have been engaged to assist with incident response and recovery efforts.

As of now, no ransomware groups have claimed responsibility for the attack on West Pharmaceutical Services.